Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 836,300 | 569,000 | 285,200 | 105,400 | 576,200 |
| Depreciation Amortization | 251,800 | 186,600 | 123,000 | 60,000 | 217,700 |
| Income taxes - deferred | 182,200 | 103,300 | -14,700 | -5,800 | -43,800 |
| Accounts receivable | -201,900 | -95,700 | -333,500 | -148,900 | -35,000 |
| Other Working Capital | 103,400 | 254,400 | 22,800 | 400 | 108,800 |
| Other Operating Activity | 268,900 | 129,100 | 404,000 | 172,700 | 165,600 |
| Operating Cash Flow | $1,440,700 | $1,146,700 | $486,800 | $183,800 | $989,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -363,500 | -261,600 | -181,100 | -87,000 | -358,800 |
| Purchase Of Investment | -1,265,800 | -1,264,600 | -1,070,700 | -462,500 | -2,657,600 |
| Sale Of Investment | 2,164,700 | 1,755,100 | 1,288,900 | 650,200 | 2,824,400 |
| Other Investing Activity | 600 | 500 | -500 | -500 | -15,500 |
| Investing Cash Flow | $536,000 | $229,400 | $36,600 | $100,200 | $-207,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,100 | 28,100 | 14,200 | 14,200 | 28,200 |
| Common Stock Repurchased | -500,000 | -187,200 | N/A | N/A | -750,000 |
| Other Financing Activity | -1,214,500 | -5,100 | -3,400 | -1,700 | -13,000 |
| Financing Cash Flow | $-1,686,400 | $-164,200 | $10,800 | $12,500 | $-734,800 |
| Exchange Rate Effect | 21,500 | 17,700 | 18,800 | 2,300 | -7,400 |
| Beginning Cash Position | 607,300 | 607,300 | 607,300 | 607,300 | 567,500 |
| End Cash Position | 919,100 | 1,836,900 | 1,160,300 | 906,100 | 607,300 |
| Net Cash Flow | $311,800 | $1,229,600 | $553,000 | $298,800 | $39,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,440,700 | 1,146,700 | 486,800 | 183,800 | 989,500 |
| Capital Expenditure | -363,500 | -261,600 | -181,100 | -87,000 | -358,800 |
| Free Cash Flow | 1,077,200 | 885,100 | 305,700 | 96,800 | 630,700 |